Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Preda

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|June 22, 2023
Editorial: Case reports in neuropharmacology 2022Adrian Preda
Annals of Internal Medicine|July 18, 2012
ACP Journal Club. Review: lithium is associated with adverse events in patients with mood disordersAdrian Preda
The American Journal of Psychiatry|May 2, 2006
Do schizophrenia patients want to be involved in their treatment?Adrian Preda
The Lancet. Psychiatry|June 17, 2026
AI-associated delusions: terminologyAdrian Preda
The Journal of Clinical Psychiatry|March 28, 2008
Shared decision making in schizophrenia treatmentAdrian Preda
The Journal of Clinical Psychiatry|October 27, 2007
Sponsored clinical trials and biasAdrian Preda
Annals of Internal Medicine|November 20, 2013
ACP Journal Club. Review: antipsychotic drugs improve symptoms, with different levels of side effects, in schizophreniaAdrian Preda
Frontiers in Pharmacology|October 27, 2023
Editorial: Be positive about the negative in pharmacology: Neuropharmacology 2022Adrian Preda, Rene Oliveira Beleboni
Southern Medical Journal|May 25, 2011
The self and Asperger syndromeRobert G Bota, Adrian Preda
Expert Opinion on Drug Safety|October 16, 2020
A safety evaluation of aripiprazole in the treatment of schizophreniaAdrian Preda, Bryan B Shapiro
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|June 22, 2023
Editorial: Case reports in neuropharmacology 2022Adrian Preda
Annals of Internal Medicine|July 18, 2012
ACP Journal Club. Review: lithium is associated with adverse events in patients with mood disordersAdrian Preda
The American Journal of Psychiatry|May 2, 2006
Do schizophrenia patients want to be involved in their treatment?Adrian Preda
The Lancet. Psychiatry|June 17, 2026
AI-associated delusions: terminologyAdrian Preda
The Journal of Clinical Psychiatry|March 28, 2008
Shared decision making in schizophrenia treatmentAdrian Preda
The Journal of Clinical Psychiatry|October 27, 2007
Sponsored clinical trials and biasAdrian Preda
Annals of Internal Medicine|November 20, 2013
ACP Journal Club. Review: antipsychotic drugs improve symptoms, with different levels of side effects, in schizophreniaAdrian Preda
Frontiers in Pharmacology|October 27, 2023
Editorial: Be positive about the negative in pharmacology: Neuropharmacology 2022Adrian Preda, Rene Oliveira Beleboni
Southern Medical Journal|May 25, 2011
The self and Asperger syndromeRobert G Bota, Adrian Preda
Expert Opinion on Drug Safety|October 16, 2020
A safety evaluation of aripiprazole in the treatment of schizophreniaAdrian Preda, Bryan B Shapiro
Pageof 13